AGLE logo

Aeglea BioTherapeutics (AGLE) Total Liabilities

AGLE Annual Total Liabilities

$20.84 M
-$5.15 M-19.80%

31 December 2022

AGLE Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AGLE Quarterly Total Liabilities

$452.67 M
+$1.77 M+0.39%

30 September 2023

AGLE Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AGLE Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.8%+1785.3%
3 y3 years-9.8%+2238.5%
5 y5 years+263.1%+5859.3%

AGLE Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-19.8%at high

Aeglea BioTherapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2023
-
$452.67 M(+0.4%)
June 2023
-
$450.90 M(+2298.3%)
Mar 2023
-
$18.80 M(-9.8%)
Dec 2022
$20.84 M(-19.8%)
$20.84 M(-13.2%)
Sept 2022
-
$24.01 M(+6.5%)
June 2022
-
$22.55 M(+4.8%)
Mar 2022
-
$21.51 M(-17.2%)
Dec 2021
$25.98 M(+19.3%)
$25.98 M(-3.7%)
Sept 2021
-
$26.98 M(-3.5%)
June 2021
-
$27.96 M(-29.9%)
Mar 2021
-
$39.86 M(+83.0%)
Dec 2020
$21.79 M(-5.7%)
$21.79 M(+12.5%)
Sept 2020
-
$19.36 M(-6.3%)
June 2020
-
$20.65 M(-6.0%)
Mar 2020
-
$21.98 M(-4.9%)
Dec 2019
$23.10 M
$23.10 M(+13.8%)
Sept 2019
-
$20.30 M(+13.5%)
June 2019
-
$17.88 M(+46.2%)
DateAnnualQuarterly
Mar 2019
-
$12.23 M(+18.6%)
Dec 2018
$10.31 M(+79.6%)
$10.31 M(+35.7%)
Sept 2018
-
$7.60 M(+21.2%)
June 2018
-
$6.27 M(+6.8%)
Mar 2018
-
$5.87 M(+2.2%)
Dec 2017
$5.74 M(+40.1%)
$5.74 M(+14.9%)
Sept 2017
-
$4.99 M(+10.0%)
June 2017
-
$4.54 M(+11.2%)
Mar 2017
-
$4.08 M(-0.3%)
Dec 2016
$4.10 M(+60.7%)
$4.10 M(+6.1%)
Sept 2016
-
$3.86 M(+14.4%)
June 2016
-
$3.38 M(-12.1%)
Mar 2016
-
$3.84 M(+50.7%)
Dec 2015
$2.55 M(+141.0%)
$2.55 M(+4.0%)
Sept 2015
-
$2.45 M(-10.5%)
June 2015
-
$2.74 M(+122.6%)
Mar 2015
-
$1.23 M(+16.3%)
Dec 2014
$1.06 M(-25.1%)
$1.06 M
Dec 2013
$1.41 M
-

FAQ

  • What is Aeglea BioTherapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Aeglea BioTherapeutics?
  • What is Aeglea BioTherapeutics annual total liabilities year-on-year change?
  • What is Aeglea BioTherapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Aeglea BioTherapeutics?
  • What is Aeglea BioTherapeutics quarterly total liabilities year-on-year change?

What is Aeglea BioTherapeutics annual total liabilities?

The current annual total liabilities of AGLE is $20.84 M

What is the all time high annual total liabilities for Aeglea BioTherapeutics?

Aeglea BioTherapeutics all-time high annual total liabilities is $25.98 M

What is Aeglea BioTherapeutics annual total liabilities year-on-year change?

Over the past year, AGLE annual total liabilities has changed by -$5.15 M (-19.80%)

What is Aeglea BioTherapeutics quarterly total liabilities?

The current quarterly total liabilities of AGLE is $452.67 M

What is the all time high quarterly total liabilities for Aeglea BioTherapeutics?

Aeglea BioTherapeutics all-time high quarterly total liabilities is $452.67 M

What is Aeglea BioTherapeutics quarterly total liabilities year-on-year change?

Over the past year, AGLE quarterly total liabilities has changed by +$428.66 M (+1785.25%)